Replies to post #2910 on Cassava Sciences Inc (SAVA)

[crescentmotor]

You mean AD peer reviewed study that showed 2 patients improved?

You conveniently forgot to mention that Blarcasamine has already demonstrated cognitive improvements in a successful Rett's Syndrome Phase III trial (in a difficult adult population) as well as in a Parkinson's Disease Dementia Phase II trial. But we can revisit cognition improvement this fall when the now fully enrolled 509 patient AD Phase 2b/III reports out.